Experimental LCL161 Combo Therapy Boosts Immunity and Shrinks Tumors in Myeloma Patients
By activating the immune system, the experimental drug LCL161…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Myeloma UK Launches Reolysin Combo Trial for Relapsing Myeloma Patients
The cancer charity Myeloma UK has launched a Phase 1…
Patient Power Backs Multiple Myeloma Patient’s Quest to Run 101st Marathon
Don Wright, who recently finished his 100th marathon while…
WT-1 Cancer Vaccine Could Benefit Myeloma Patients Undergoing Stem Cell Transplants
Multiple myeloma patients undergoing autologous stem cell transplants (ASCT)…
Early Studies of 2 Possible Multiple Myeloma Treatments to Be Presented at AACR
GlycoMimetics will present preclinical research at the…
Celyad’s Trial Evaluating CAR T-cells in 7 Cancers to Start Enrolling Patients in US
Celyad is ready to enroll patients in its Phase 1…
